(Q48646925)

13 February 2018

title

Measles vaccination of macaques by dry powder inhalation. (English)

1 reference

13 February 2018

1 reference

16

1 reference

13 February 2018

Rik L. de Swart

Rik L de Swart

1

0 references

Thijs Kuiken

13

Thijs Kuiken

1 reference

13 February 2018

Geert van Amerongen

4

Geert van Amerongen

1 reference

13 February 2018

Selma Yüksel

7

Selma Yüksel

1 reference

13 February 2018

author name string

Cynthia LiCalsi

2

1 reference

13 February 2018

Alan V Quirk

3

1 reference

13 February 2018

Vladislav Nodelman

5

1 reference

13 February 2018

Robert Alcock

6

1 reference

13 February 2018

Gary H Ward

8

1 reference

13 February 2018

John G Hardy

9

1 reference

13 February 2018

Helma Vos

10

1 reference

13 February 2018

Clyde L Witham

11

1 reference

13 February 2018

Christopher I Grainger

12

1 reference

13 February 2018

Bernard J Greenspan

14

1 reference

13 February 2018

Trevor G Gard

15

1 reference

13 February 2018

language of work or name

English

0 references

publication date

23 October 2006

1 reference

13 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

13 February 2018

volume

25

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

1183-1190

1 reference

13 February 2018

Experience in Global Measles Control, 1990–2001

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Public-health impact of accelerated measles control in the WHO African Region 2000-03.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Measles: the need for 2 opportunities for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Measles elimination: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Alternative routes of measles immunization: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Dry powder inhalation as a potential delivery method for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

A powder formulation of measles vaccine for aerosol delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Vaccination against measles: a neverending story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Experimental vaccines against measles in a world of changing epidemiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Aerosol measles vaccination in macaques: Preclinical studies of immune responses and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Administration of an insulin powder to the lungs of cynomolgus monkeys using a Penn Century insufflator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Development of a semi-quantitative real-time RT-PCR for the detection of measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Role of virus strain dm conventional and enhanced measles plaque neutralization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Viral replication and development of specific immunity in macaques after infection with different measles virus strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

Dry powder inhalers for pulmonary drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.019

10.1016/J.VACCINE.2006.10.019

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

17084489

1 reference

13 February 2018